S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   98.70 (-1.90%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   94.90 (-1.70%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   293.90 (-3.89%)
S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   98.70 (-1.90%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   94.90 (-1.70%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   293.90 (-3.89%)
S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   98.70 (-1.90%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   94.90 (-1.70%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   293.90 (-3.89%)
S&P 500   3,936.97 (-1.65%)
DOW   32,030.11 (-1.63%)
QQQ   306.12 (-1.36%)
AAPL   157.83 (-0.91%)
MSFT   272.29 (-0.54%)
META   199.81 (-1.16%)
GOOGL   103.37 (-1.48%)
AMZN   98.70 (-1.90%)
TSLA   191.15 (-3.25%)
NVDA   264.68 (+1.03%)
NIO   9.09 (-1.94%)
BABA   83.65 (-0.06%)
AMD   97.58 (+1.72%)
T   18.39 (-0.81%)
F   11.48 (-2.05%)
MU   58.17 (-0.78%)
CGC   1.88 (-4.57%)
GE   89.59 (-2.81%)
DIS   94.90 (-1.70%)
AMC   4.34 (-1.59%)
PFE   40.01 (-1.60%)
PYPL   74.34 (-3.10%)
NFLX   293.90 (-3.89%)

Baxter International - BAX Stock Forecast, Price & News

$39.16
-0.45 (-1.14%)
(As of 03/22/2023 05:24 PM ET)
Add
Compare
Today's Range
$39.13
$40.15
50-Day Range
$37.58
$47.01
52-Week Range
$37.35
$80.72
Volume
6.56 million shs
Average Volume
6.71 million shs
Market Capitalization
$19.76 billion
P/E Ratio
N/A
Dividend Yield
2.96%
Price Target
$55.14

Baxter International MarketRank™ Forecast

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
40.8% Upside
$55.14 Price Target
Short Interest
Healthy
0.83% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
0.27mentions of Baxter International in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$2.96 M Sold Last Quarter
Proj. Earnings Growth
15.85%
From $2.84 to $3.29 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.98 out of 5 stars

Medical Sector

34th out of 983 stocks

Surgical & Medical Instruments Industry

3rd out of 100 stocks


BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Check Out This 6-Year Win Streak
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
See More Headlines
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Ex-Dividend for 1/3 Dividend
12/01/2022
Dividend Payable
1/03/2023
Last Earnings
2/09/2023
Ex-Dividend for 4/3 Dividend
2/23/2023
Today
3/22/2023
Dividend Payable
4/03/2023
Next Earnings (Estimated)
4/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$55.14
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+38.4%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
12 Analysts

Profitability

Net Income
$-2,433,000,000.00
Pretax Margin
-15.57%

Debt

Sales & Book Value

Annual Sales
$15.11 billion
Cash Flow
$13.32 per share
Book Value
$11.69 per share

Miscellaneous

Free Float
503,612,000
Market Cap
$20.11 billion
Optionable
Optionable
Beta
0.55

Social Links


Key Executives

  • Joe Almeida
    Chairman, President & Chief Executive Officer
  • James K. Saccaro
    Chief Financial Officer & Executive Vice President
  • Paulo Henrique Bolgar
    Vice President-Research & Development
  • Reaz Rasul
    EVP, President-Healthcare Systems & Technologies
  • Tobi Karchmer
    Chief Medical Officer & Senior Vice President













BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 1 sell rating, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings
or view top-rated stocks.

What is Baxter International's stock price forecast for 2023?

12 Wall Street analysts have issued 12-month target prices for Baxter International's shares. Their BAX share price forecasts range from $43.00 to $75.00. On average, they expect the company's stock price to reach $55.14 in the next year. This suggests a possible upside of 37.7% from the stock's current price.
View analysts price targets for BAX
or view top-rated stocks among Wall Street analysts.

How have BAX shares performed in 2023?

Baxter International's stock was trading at $50.97 at the start of the year. Since then, BAX shares have decreased by 21.4% and is now trading at $40.06.
View the best growth stocks for 2023 here
.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest in February. As of February 28th, there was short interest totaling 4,170,000 shares, an increase of 12.7% from the February 13th total of 3,700,000 shares. Based on an average daily trading volume, of 6,030,000 shares, the short-interest ratio is currently 0.7 days.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our BAX earnings forecast
.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) posted its quarterly earnings data on Thursday, February, 9th. The medical instruments supplier reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.94 by $0.06. The medical instruments supplier earned $3.89 billion during the quarter, compared to analyst estimates of $3.77 billion. Baxter International had a positive trailing twelve-month return on equity of 24.03% and a negative net margin of 16.10%. Baxter International's quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.04 EPS.
Read the conference call transcript
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, February 14th. Shareholders of record on Friday, February 24th will be given a dividend of $0.29 per share on Monday, April 3rd. This represents a $1.16 dividend on an annualized basis and a yield of 2.90%. The ex-dividend date of this dividend is Thursday, February 23rd.
Read our dividend analysis for BAX
.

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 3.09%.
Read our dividend analysis for BAX.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its first quarter 2023 earnings guidance on Thursday, February, 9th. The company provided EPS guidance of $0.46-$0.50 for the period, compared to the consensus EPS estimate of $0.76. The company issued revenue guidance of $3.60 billion-$3.60 billion, compared to the consensus revenue estimate of $3.61 billion.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.75%), Amundi (0.78%), California Public Employees Retirement System (0.67%), Cooke & Bieler LP (0.50%), Coho Partners Ltd. (0.39%) and Cincinnati Financial Corp (0.32%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends
.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $40.06.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $20.22 billion and generates $15.11 billion in revenue each year. The medical instruments supplier earns $-2,433,000,000.00 in net income (profit) each year or ($4.83) on an earnings per share basis.

How many employees does Baxter International have?

The company employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?
The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More
How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 3/22/2023 by MarketBeat.com Staff